NCT02219087 - Liposomal Bupivacaine Versus Standard of Care in Total Knee Surgery | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

Osteoarthritis, Knee

Interventions

DRUG

Liposomal bupivacaine

DRUG

Standard of Care

Pre-operative adductor canal nerve block (20mL of 0.5% ropivacaine). Intra-operative popliteal nerve block from the surgeon: 20mL 0.2% ropivacaine and a peri-articular injection of 10mg morphine, 30mg ketorolac and 40mg methylprednisolone.

Trial Locations (1)

43215

OhioHealth Grant Medical Center Bone and Joint Center, Columbus